Y
Yoshiya Tanaka
Researcher at University of Occupational and Environmental Health Japan
Publications - 1102
Citations - 33844
Yoshiya Tanaka is an academic researcher from University of Occupational and Environmental Health Japan. The author has contributed to research in topics: Rheumatoid arthritis & Medicine. The author has an hindex of 78, co-authored 965 publications receiving 27760 citations. Previous affiliations of Yoshiya Tanaka include Saitama Medical University & Mitsubishi Tanabe Pharma.
Papers
More filters
Journal ArticleDOI
Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011
Hisanori Umehara,Kazuichi Okazaki,Yasufumi Masaki,Mitsuhiro Kawano,Motohisa Yamamoto,Takako Saeki,Shoko Matsui,Tadashi Yoshino,Shigeo Nakamura,Shigeyuki Kawa,Hideaki Hamano,Terumi Kamisawa,Toru Shimosegawa,Akira Shimatsu,Seiji Nakamura,Tetsuhide Ito,Kenji Notohara,Takayuki Sumida,Yoshiya Tanaka,Tsuneyo Mimori,Tsutomu Chiba,Michiaki Mishima,Toshifumi Hibi,Hirohito Tsubouchi,Kazuo Inui,Hirotaka Ohara +25 more
TL;DR: The comprehensive diagnostic criteria for IgG4-RD are practically useful for general physicians and nonspecialists and have increased the sensitivity of diagnosis to 100% for Igg4-related MD, KD, and AIP.
Journal ArticleDOI
T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1 beta.
Yoshiya Tanaka,David H. Adams,Stefan G. Hubscher,Hiroyuki Hirano,Ulrich Siebenlist,Stephen Shaw +5 more
TL;DR: It is proposed that MIP-1β and other cytokines with glycosaminoglycan-binding sites will bind to and be presented by endothelial proteoglycans to trigger adhesion selectively not only of lymphocyte subsets, but also of other cell types.
Journal ArticleDOI
A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details
Hisanori Umehara,Kazuichi Okazaki,Yasufumi Masaki,Mitsuhiro Kawano,Motohisa Yamamoto,Takako Saeki,Shoko Matsui,Takayuki Sumida,Tsuneyo Mimori,Yoshiya Tanaka,Kazuo Tsubota,Tadashi Yoshino,Shigeyuki Kawa,Ritsuro Suzuki,Tsutomu Takegami,Naohisa Tomosugi,Nozomu Kurose,Yasuhito Ishigaki,Atsushi Azumi,Masaru Kojima,Shigeo Nakamura,Dai Inoue +21 more
TL;DR: Although IgG4RD forms a distinct, clinically independent disease category and is attracting strong attention as a new clinical entity, many questions and problems still remain to be elucidated, including its pathogenesis, the establishment of diagnostic criteria, and the role of IgG 4.
Journal ArticleDOI
Lymphocyte interactions with endothelial cells.
TL;DR: The molecules that mediate lymphocyte-endothelial cell adhesion are identified, the underlying principles of lymphocyte migration are described, and a model of the sequence of events that allow a lymphocyte to successfully attach to endothelium and migrate into the surrounding tissue is discussed.
Journal ArticleDOI
Trial of Anifrolumab in Active Systemic Lupus Erythematosus
Eric F Morand,Richard Furie,Yoshiya Tanaka,Ian N. Bruce,Anca Askanase,Christophe Richez,Sang Cheol Bae,Philip Z Brohawn,Lilia Pineda,Anna Berglind,Raj Tummala,Tulip Trial Investigators +11 more
TL;DR: Anifrolumab, a human monoclonal antibody to type I interferon receptor subunit 1 investigated for the treatment of systemic lupus erythematosus (SLE), did not have a significant effect as discussed by the authors.